All updated as on -
With a CAGR of 30.2% between 2023 and 2030, the global market for cognitive evaluation and training in healthcare is expected to expand from its 2023 valuation of $3.98 billion to $29 billion.
Cognition is the mental process by which one acquires information through one's senses, thoughts, and understanding. Assessment of mental faculties is called cognitive testing. It has found use in a variety of settings, including laboratories, hospitals, universities, and corporations for the purpose of evaluating job candidates and existing staff members. The exam is also utilised in the detection of MCI (Mild Cognitive Impairment). As disorders like MCI become more common, there is a greater need for cognitive testing and education in the medical field. For instance, in 2022, a study report published by Frontiers Media S.A. estimated that the worldwide prevalence of MCI was between 15 and 20%. The expansion efforts of existing market players have also contributed to the development of the worldwide market for cognitive assessment and training in healthcare. The growing elderly population also poses a greater threat of mental decline. Therefore, it is projected that the expansion of the market during the forecast period will be contributed to by the rise of the geriatric population in regional markets.
Better availability to technology and the advent of telemedicine enhanced the need for online cognitive evaluation and training options during the pandemic, helping to reduce the severity of the first losses. With the discovery of neurological effects in COVID-19 patients, monitoring cognitive capacity has emerged as an essential task, driving market expansion. More than 153 million people will have dementia by 2050, up from 57 million in 2019, according to the Alzheimer's Association. The ageing of the population is the primary driver of this projected growth. The World Health Organisation reported in February 2019 that the global population of people aged 60 and up would increase to 1.4 billion by 2030.
The purpose of this report is to define, describe, and forecast the market based on assessment types, components (solutions and services), applications, and regions, as well as to provide information about the major drivers, restraints, opportunities, and challenges influencing the growth of the market. The global market for cognitive assessment and training in healthcare was estimated and validated using both top-down and bottom-up methodologies, along with estimates for several dependent submarkets. Market leaders were identified via secondary research, and their regional market shares were calculated from primary and secondary sources. Researching the annual and financial reports of major market competitors and conducting in-depth interviews with important industry figures are both integral parts of this process. All percentages, breakdowns, and distributions were calculated with the use of secondary sources and double-checked with primary ones. This study takes into account every factor that could have an impact on the market, examines these factors in great depth, confirms these findings using primary research, and then analyses the results quantitatively and qualitatively. MarketsandMarkets takes this information and adds their own in-depth research and analysis. In-depth interviews with CEOs, VPs, Directors, and executives were also carried out in order to gain insight into the market trend.
Cognitive assessments are useful in clinical trials because they can detect changes in a patient's cognitive performance that may indicate the medicine is having an effect. This is useful for determining if the patient's cognitive abilities have worsened or improved as a result of treatment. The COVID-19 pandemic sparked a new trend towards using virtual clinical trials as a means of containing the disease. Clinical trials conducted online are often known as remote trials or decentralised studies. Virtual patient monitoring, wearable medical devices, remote SDV, and other cutting-edge technology are all utilised in this kind of clinical experiment. Market expansion has been aided by decentralised clinical trials, in which patients can take part from a distance and be digitally monitored. Recent years have seen a rise in the popularity of decentralised clinical trials due to their ability to remove patients' geographical constraints from research investigations. According to one 2023 mdgroup post, 70% of patients are not present for monitoring for more than 2 hours at the research site. While in decentralised trials, researchers can keep an eye on patients whenever they choose. Patients who have previously enrolled can complete the cognitive assessment form online, saving them a trip to the research centre. Researchers don't even need to see the patients in person to analyse the tests. Virtual clinical trials have benefited greatly from the use of digital cognitive testing and training in healthcare. This is what has driven the market forward and raised patient awareness of digital cognitive exams.
The investigation of cognitive alterations in both preclinical and clinical investigations of neurological disorders like Alzheimer's is crucial. As a result, the demand for cognitive testing has been growing in tandem with the proliferation of clinical studies for these illnesses. For instance, 172 Alzheimer's disease clinical trials involving 143 different treatment candidates were conducted between 2000 and January 2022, as reported by the National Centre for Biotechnology Information (NCBI). The current clinical investigations necessitated participation from 50,575 participants. These patients also require routine assessments of their cognition.
The need for cognitive assessment tests has risen in recent years alongside the rising profile of such evaluations. However, widespread use is hindered by the high prices of computerised cognitive evaluations. Digital assessment, for instance, might cost anything from $10 to $50 each test in the United States. Cognitive assessment and training in healthcare is an area where market participants are actively working to offer novel solutions and services. However, clinical trials are required to verify the efficacy of these remedies and grant permission for their commercialization. It may take a long time for these solutions to be developed and approved. In addition, as disorders like Alzheimer's and dementia become more common, people are searching for better, longer-lasting treatments. As a result, it may take longer for people to implement these kinds of solutions. Growth in the market is likely to be hindered by these variables over the projected timeline.
Report Coverage
Global Cognitive Assessment and Training in Healthcare research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cognitive Assessment and Training in Healthcare report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cognitive Assessment and Training in Healthcare competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cognitive Assessment and Training in Healthcare market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cognitive Assessment and Training in Healthcare market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cognitive Assessment and Training in Healthcare market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Cambridge Cognition Ltd. (Cambridge, U.K.), Cogstate Ltd. (New Haven, U.S.), Bracket (Pennsylvania, U.S.), MedAvante, Inc. (New Jersey, U.S.), Quest Diagnostic (New Jersey, U.S.), ProPhase, LLC (New York, U.S.), CogniFit (New York, U.S.), ERT Clinical (Pennsylvania, U.S.), NeuroCog Trials (North Carolina, U.S.), and Brain Resource Company (New South Wales, Australia), Cognetivity Neurosciences, Clario, Posit Science, Signant Health, WIRB-Copernicus Group, CNS Vital Signs
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cognitive Assessment and Training in Healthcare market based on the below-mentioned segments:
Global Cognitive Assessment and Training in Healthcare Market, By Type
Pen-and-Paper based assessment
Hosted assessment
Biometrics assessment
Global Cognitive Assessment and Training in Healthcare market, By Solutions
Assessment
Data management
Project management
Data analysis and reporting
Others
Global Cognitive Assessment and Training in Healthcare Market, By Applications
Clinical trials
Screening and diagnostic
Brain training
Academic research
Others
Global Cognitive Assessment and Training in Healthcare market, Regional Analysis
Cognition is the mental process by which one acquires information through one's senses, thoughts, and understanding. Assessment of mental faculties is called cognitive testing. It has found use in a variety of settings, including laboratories, hospitals, universities, and corporations for the purpose of evaluating job candidates and existing staff members. The exam is also utilised in the detection of MCI (Mild Cognitive Impairment). As disorders like MCI become more common, there is a greater need for cognitive testing and education in the medical field. For instance, in 2022, a study report published by Frontiers Media S.A. estimated that the worldwide prevalence of MCI was between 15 and 20%. The expansion efforts of existing market players have also contributed to the development of the worldwide market for cognitive assessment and training in healthcare. The growing elderly population also poses a greater threat of mental decline. Therefore, it is projected that the expansion of the market during the forecast period will be contributed to by the rise of the geriatric population in regional markets.
Better availability to technology and the advent of telemedicine enhanced the need for online cognitive evaluation and training options during the pandemic, helping to reduce the severity of the first losses. With the discovery of neurological effects in COVID-19 patients, monitoring cognitive capacity has emerged as an essential task, driving market expansion. More than 153 million people will have dementia by 2050, up from 57 million in 2019, according to the Alzheimer's Association. The ageing of the population is the primary driver of this projected growth. The World Health Organisation reported in February 2019 that the global population of people aged 60 and up would increase to 1.4 billion by 2030.
The purpose of this report is to define, describe, and forecast the market based on assessment types, components (solutions and services), applications, and regions, as well as to provide information about the major drivers, restraints, opportunities, and challenges influencing the growth of the market. The global market for cognitive assessment and training in healthcare was estimated and validated using both top-down and bottom-up methodologies, along with estimates for several dependent submarkets. Market leaders were identified via secondary research, and their regional market shares were calculated from primary and secondary sources. Researching the annual and financial reports of major market competitors and conducting in-depth interviews with important industry figures are both integral parts of this process. All percentages, breakdowns, and distributions were calculated with the use of secondary sources and double-checked with primary ones. This study takes into account every factor that could have an impact on the market, examines these factors in great depth, confirms these findings using primary research, and then analyses the results quantitatively and qualitatively. MarketsandMarkets takes this information and adds their own in-depth research and analysis. In-depth interviews with CEOs, VPs, Directors, and executives were also carried out in order to gain insight into the market trend.
Cognitive assessments are useful in clinical trials because they can detect changes in a patient's cognitive performance that may indicate the medicine is having an effect. This is useful for determining if the patient's cognitive abilities have worsened or improved as a result of treatment. The COVID-19 pandemic sparked a new trend towards using virtual clinical trials as a means of containing the disease. Clinical trials conducted online are often known as remote trials or decentralised studies. Virtual patient monitoring, wearable medical devices, remote SDV, and other cutting-edge technology are all utilised in this kind of clinical experiment. Market expansion has been aided by decentralised clinical trials, in which patients can take part from a distance and be digitally monitored. Recent years have seen a rise in the popularity of decentralised clinical trials due to their ability to remove patients' geographical constraints from research investigations. According to one 2023 mdgroup post, 70% of patients are not present for monitoring for more than 2 hours at the research site. While in decentralised trials, researchers can keep an eye on patients whenever they choose. Patients who have previously enrolled can complete the cognitive assessment form online, saving them a trip to the research centre. Researchers don't even need to see the patients in person to analyse the tests. Virtual clinical trials have benefited greatly from the use of digital cognitive testing and training in healthcare. This is what has driven the market forward and raised patient awareness of digital cognitive exams.
The investigation of cognitive alterations in both preclinical and clinical investigations of neurological disorders like Alzheimer's is crucial. As a result, the demand for cognitive testing has been growing in tandem with the proliferation of clinical studies for these illnesses. For instance, 172 Alzheimer's disease clinical trials involving 143 different treatment candidates were conducted between 2000 and January 2022, as reported by the National Centre for Biotechnology Information (NCBI). The current clinical investigations necessitated participation from 50,575 participants. These patients also require routine assessments of their cognition.
The need for cognitive assessment tests has risen in recent years alongside the rising profile of such evaluations. However, widespread use is hindered by the high prices of computerised cognitive evaluations. Digital assessment, for instance, might cost anything from $10 to $50 each test in the United States. Cognitive assessment and training in healthcare is an area where market participants are actively working to offer novel solutions and services. However, clinical trials are required to verify the efficacy of these remedies and grant permission for their commercialization. It may take a long time for these solutions to be developed and approved. In addition, as disorders like Alzheimer's and dementia become more common, people are searching for better, longer-lasting treatments. As a result, it may take longer for people to implement these kinds of solutions. Growth in the market is likely to be hindered by these variables over the projected timeline.
Report Coverage
Global Cognitive Assessment and Training in Healthcare research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cognitive Assessment and Training in Healthcare report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cognitive Assessment and Training in Healthcare competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cognitive Assessment and Training in Healthcare market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Cambridge Cognition Ltd. (Cambridge, U.K.), Cogstate Ltd. (New Haven, U.S.), Bracket (Pennsylvania, U.S.), MedAvante, Inc. (New Jersey, U.S.), Quest Diagnostic (New Jersey, U.S.), ProPhase, LLC (New York, U.S.), CogniFit (New York, U.S.), ERT Clinical (Pennsylvania, U.S.), NeuroCog Trials (North Carolina, U.S.), and Brain Resource Company (New South Wales, Australia), Cognetivity Neurosciences, Clario, Posit Science, Signant Health, WIRB-Copernicus Group, CNS Vital Signs |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cognitive Assessment and Training in Healthcare Market from 2021 to 2030.
- Market Forecast for Cognitive Assessment and Training in Healthcare Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cognitive Assessment and Training in Healthcare competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cognitive Assessment and Training in Healthcare
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cognitive Assessment and Training in Healthcare market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cognitive Assessment and Training in Healthcare market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Cambridge Cognition Ltd. (Cambridge, U.K.), Cogstate Ltd. (New Haven, U.S.), Bracket (Pennsylvania, U.S.), MedAvante, Inc. (New Jersey, U.S.), Quest Diagnostic (New Jersey, U.S.), ProPhase, LLC (New York, U.S.), CogniFit (New York, U.S.), ERT Clinical (Pennsylvania, U.S.), NeuroCog Trials (North Carolina, U.S.), and Brain Resource Company (New South Wales, Australia), Cognetivity Neurosciences, Clario, Posit Science, Signant Health, WIRB-Copernicus Group, CNS Vital Signs
Primary Target Market
- Market Players of Cognitive Assessment and Training in Healthcare
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cognitive Assessment and Training in Healthcare market based on the below-mentioned segments:
Global Cognitive Assessment and Training in Healthcare Market, By Type
Pen-and-Paper based assessment
Hosted assessment
Biometrics assessment
Global Cognitive Assessment and Training in Healthcare market, By Solutions
Assessment
Data management
Project management
Data analysis and reporting
Others
Global Cognitive Assessment and Training in Healthcare Market, By Applications
Clinical trials
Screening and diagnostic
Brain training
Academic research
Others
Global Cognitive Assessment and Training in Healthcare market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cognitive assessment and training in healthcare market market research and competitor analysis for your business to help you develop more profound insights into the cognitive assessment and training in healthcare market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cognitive assessment and training in healthcare market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.